Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma

Abstract Background Patients with metastatic hepatoblastoma are treated with severely toxic first-line chemotherapies in combination with surgery. Yet, inadequate response of lung metastases to neo-adjuvant chemotherapy still compromises patient outcomes making new treatment strategies, tailored to...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Salih Demir, Alina Hotes, Tanja Schmid, Stefano Cairo, Emilie Indersie, Claudio Pisano, Eiso Hiyama, Tomoro Hishiki, Christian Vokuhl, Sophie Branchereau, Penelope Brock, Irene Schmid, József Zsiros, Roland Kappler
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2024-11-01
Цуврал:	Journal of Experimental & Clinical Cancer Research
Нөхцлүүд:	Hepatoblastoma Metastasis Panobinostat Therapy MYC
Онлайн хандалт:	https://doi.org/10.1186/s13046-024-03221-6
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!